AKT1 and hepatocellular carcinoma: IGF2BP1 can recognize circMDK via m6A sites, activate the PI3K/AKT/mTOR signaling pathway through the miR-346/874-3p-ATG16L1 axis, and ultimately promote the proliferation, migration and invasion of hepatoma cells (56).